R

Ratio Therapeutics

17 employees

Ratio Therapeutics is a clinical phase pharmaceutical company that develops radiopharmaceuticals for solid tumors.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Pharmaceutical

Date founded

2021

Funding rounds raised

Total raised

$20M

from 1 investors over 1 rounds

R

Ratio Therapeutics raised $20M on February 1, 2023

Investors: Schusterman Family Investments (SFI)

FAQ